Literature DB >> 23612460

Beyond TGFβ: roles of other TGFβ superfamily members in cancer.

Lalage M Wakefield1, Caroline S Hill.   

Abstract

Much of the focus on the transforming growth factor-β (TGFβ) superfamily in cancer has revolved around the TGFβ ligands themselves. However, it is now becoming apparent that deregulated signalling by many of the other superfamily members also has crucial roles in both the development of tumours and metastasis. Furthermore, these signalling pathways are emerging as plausible therapeutic targets. Their roles in tumorigenesis frequently reflect their function in embryonic development or in adult tissue homeostasis, and their influence extends beyond the tumours themselves, to the tumour microenvironment and more widely to complications of cancer such as cachexia and bone loss.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23612460      PMCID: PMC7608560          DOI: 10.1038/nrc3500

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  113 in total

Review 1.  Extrinsic regulation of pluripotent stem cells.

Authors:  Martin F Pera; Patrick P L Tam
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

2.  Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-beta signaling.

Authors:  Geeta Upadhyay; Yuzhi Yin; Hongyan Yuan; Xin Li; Rik Derynck; Robert I Glazer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

Review 3.  The regulation and functions of activin and follistatin in inflammation and immunity.

Authors:  Mark P Hedger; Wendy R Winnall; David J Phillips; David M de Kretser
Journal:  Vitam Horm       Date:  2011       Impact factor: 3.421

Review 4.  The bright and the dark sides of activin in wound healing and cancer.

Authors:  Maria Antsiferova; Sabine Werner
Journal:  J Cell Sci       Date:  2012-09-18       Impact factor: 5.285

5.  Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease.

Authors:  Sonia Vallet; Siddhartha Mukherjee; Nileshwari Vaghela; Teru Hideshima; Mariateresa Fulciniti; Samantha Pozzi; Loredana Santo; Diana Cirstea; Kishan Patel; Aliyah R Sohani; Alex Guimaraes; Wanling Xie; Dharminder Chauhan; Jesse A Schoonmaker; Eyal Attar; Michael Churchill; Edie Weller; Nikhil Munshi; Jasbir S Seehra; Ralph Weissleder; Kenneth C Anderson; David T Scadden; Noopur Raje
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

6.  Nodal signaling regulates the bone morphogenic protein pluripotency pathway in mouse embryonic stem cells.

Authors:  Katherine E Galvin; Emily D Travis; Della Yee; Terry Magnuson; Jay L Vivian
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

Review 7.  Targeting the TGFβ signalling pathway in disease.

Authors:  Rosemary J Akhurst; Akiko Hata
Journal:  Nat Rev Drug Discov       Date:  2012-09-24       Impact factor: 84.694

Review 8.  Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins.

Authors:  Jennifer M Bailey; Pankaj K Singh; Michael A Hollingsworth
Journal:  J Cell Biochem       Date:  2007-11-01       Impact factor: 4.429

Review 9.  Cancer stem cells: impact, heterogeneity, and uncertainty.

Authors:  Jeffrey A Magee; Elena Piskounova; Sean J Morrison
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

10.  Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1.

Authors:  Emma Jaeger; Simon Leedham; Annabelle Lewis; Stefania Segditsas; Martin Becker; Pedro Rodenas Cuadrado; Hayley Davis; Kulvinder Kaur; Karl Heinimann; Kimberley Howarth; James East; Jenny Taylor; Huw Thomas; Ian Tomlinson
Journal:  Nat Genet       Date:  2012-05-06       Impact factor: 38.330

View more
  156 in total

1.  Screen for reactivation of MeCP2 on the inactive X chromosome identifies the BMP/TGF-β superfamily as a regulator of XIST expression.

Authors:  Smitha Sripathy; Vid Leko; Robin L Adrianse; Taylor Loe; Eric J Foss; Emily Dalrymple; Uyen Lao; Tonibelle Gatbonton-Schwager; Kelly T Carter; Bernhard Payer; Patrick J Paddison; William M Grady; Jeannie T Lee; Marisa S Bartolomei; Antonio Bedalov
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-31       Impact factor: 11.205

2.  An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.

Authors:  Michael Dussiot; Thiago T Maciel; Aurélie Fricot; Céline Chartier; Olivier Negre; Joel Veiga; Damien Grapton; Etienne Paubelle; Emmanuel Payen; Yves Beuzard; Philippe Leboulch; Jean-Antoine Ribeil; Jean-Benoit Arlet; Francine Coté; Geneviève Courtois; Yelena Z Ginzburg; Thomas O Daniel; Rajesh Chopra; Victoria Sung; Olivier Hermine; Ivan C Moura
Journal:  Nat Med       Date:  2014-03-23       Impact factor: 53.440

Review 3.  Interplay of retinal determination gene network with TGF-β signaling pathway in epithelial-mesenchymal transition.

Authors:  Yu Liu; Deguang Kong; Hua Wu; Xun Yuan; Hanxiao Xu; Cuntai Zhang; Gaosong Wu; Kongming Wu
Journal:  Stem Cell Investig       Date:  2015-06-09

Review 4.  Mechanisms governing metastatic dormancy and reactivation.

Authors:  Filippo G Giancotti
Journal:  Cell       Date:  2013-11-07       Impact factor: 41.582

5.  Differential molecular regulation of processing and membrane expression of Type-I BMP receptors: implications for signaling.

Authors:  Tal Hirschhorn; Michal Levi-Hofman; Oded Danziger; Nechama I Smorodinsky; Marcelo Ehrlich
Journal:  Cell Mol Life Sci       Date:  2017-03-29       Impact factor: 9.261

Review 6.  Immunoregulation by members of the TGFβ superfamily.

Authors:  WanJun Chen; Peter Ten Dijke
Journal:  Nat Rev Immunol       Date:  2016-11-25       Impact factor: 53.106

7.  BMP signaling requires retromer-dependent recycling of the type I receptor.

Authors:  Ryan J Gleason; Adenrele M Akintobi; Barth D Grant; Richard W Padgett
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

8.  TGFβ-Induced Lung Cancer Cell Migration Is NR4A1-Dependent.

Authors:  Erik Hedrick; Kumaravel Mohankumar; Stephen Safe
Journal:  Mol Cancer Res       Date:  2018-08-02       Impact factor: 5.852

Review 9.  SMAD7: a timer of tumor progression targeting TGF-β signaling.

Authors:  Lingyu Luo; Nianshuang Li; Nonghua Lv; Deqiang Huang
Journal:  Tumour Biol       Date:  2014-06-17

10.  Plasticity underlies tumor progression: role of Nodal signaling.

Authors:  Thomas M Bodenstine; Grace S Chandler; Richard E B Seftor; Elisabeth A Seftor; Mary J C Hendrix
Journal:  Cancer Metastasis Rev       Date:  2016-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.